Assaf Guterman

Direttore Tecnico/Scientifico/R&S presso ClearCut Medical Ltd.

Health Technology

Consumer Services

Profilo

Assaf Guterman is the founder of EndyMed Ltd.
He currently holds the position of Vice President-Research & Development at ClearCut Medical Ltd.
He has an undergraduate and graduate degree from Tel-Aviv University.

Posizioni attive di Assaf Guterman

Società	Posizione	Inizio
ClearCut Medical Ltd. ClearCut Medical Ltd. Medical SpecialtiesHealth Technology ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Assaf Guterman

Precedenti posizioni note di Assaf Guterman

Società	Posizione	Fine
ENDYMED LTD	Fondatore	-

Vedi nel dettaglio l'esperienza di Assaf Guterman

Formazione di Assaf Guterman

Tel-Aviv University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Assaf Guterman

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ENDYMED LTD	Health Technology

Aziende private	1
ClearCut Medical Ltd. ClearCut Medical Ltd. Medical SpecialtiesHealth Technology ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel.	Health Technology